Concurrently, Moody’s affirmed its “A2” rating on the health system’s $370 million outstanding debt.
The assignment and affirmation are due to WakeMed’s strong market position, solid cash flow margins and good days cash on hand. Moody’s, however, expects the health system to remain leveraged.
The outlook is stable.
More articles on healthcare finance:
State-by-state breakdown of 102 rural hospital closures
10 hospitals seeking CFOs
How New York’s ‘baseball-style’ arbitration process reduced surprise bills: 7 notes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.